These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 1567459)
1. Staurosporine is a potent inhibitor of p34cdc2 and p34cdc2-like kinases. Gadbois DM; Hamaguchi JR; Swank RA; Bradbury EM Biochem Biophys Res Commun; 1992 Apr; 184(1):80-5. PubMed ID: 1567459 [TBL] [Abstract][Full Text] [Related]
2. Staurosporine- and radiation-induced G2-phase cell cycle blocks are equally released by caffeine. Crompton NE; Hain J; Jaussi R; Burkart W Radiat Res; 1993 Sep; 135(3):372-9. PubMed ID: 8378530 [TBL] [Abstract][Full Text] [Related]
3. UCN-01 abrogates G2 arrest through a Cdc2-dependent pathway that is associated with inactivation of the Wee1Hu kinase and activation of the Cdc25C phosphatase. Yu L; Orlandi L; Wang P; Orr MS; Senderowicz AM; Sausville EA; Silvestrini R; Watanabe N; Piwnica-Worms H; O'Connor PM J Biol Chem; 1998 Dec; 273(50):33455-64. PubMed ID: 9837924 [TBL] [Abstract][Full Text] [Related]
4. Regulation of the cell cycle at the G2/M boundary in metastatic melanoma cells by 12-O-tetradecanoyl phorbol-13-acetate (TPA) by blocking p34cdc2 kinase activity. Arita Y; Buffolino P; Coppock DL Exp Cell Res; 1998 Aug; 242(2):381-90. PubMed ID: 9683525 [TBL] [Abstract][Full Text] [Related]
5. Transformed mammalian cells are deficient in kinase-mediated control of progression through the G1 phase of the cell cycle. Crissman HA; Gadbois DM; Tobey RA; Bradbury EM Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7580-4. PubMed ID: 1652754 [TBL] [Abstract][Full Text] [Related]
6. Different mechanisms for inhibition of cell proliferation via cell cycle proteins in PC12 cells by nerve growth factor and staurosporine. Gollapudi L; Neet KE J Neurosci Res; 1997 Aug; 49(4):461-74. PubMed ID: 9285522 [TBL] [Abstract][Full Text] [Related]
7. Requirement for p34cdc2 kinase is restricted to mitosis in the mammalian cdc2 mutant FT210. Hamaguchi JR; Tobey RA; Pines J; Crissman HA; Hunter T; Bradbury EM J Cell Biol; 1992 Jun; 117(5):1041-53. PubMed ID: 1533642 [TBL] [Abstract][Full Text] [Related]
8. Role of tyrosine phosphorylation in radiation-induced cell cycle-arrest of leukemic B-cell precursors at the G2-M transition checkpoint. Tuel-Ahlgren L; Jun X; Waddick KG; Jin J; Bolen J; Uckun FM Leuk Lymphoma; 1996 Feb; 20(5-6):417-26. PubMed ID: 8833397 [TBL] [Abstract][Full Text] [Related]
9. Potent inhibition of CDC2 kinase activity by the flavonoid L86-8275. Losiewicz MD; Carlson BA; Kaur G; Sausville EA; Worland PJ Biochem Biophys Res Commun; 1994 Jun; 201(2):589-95. PubMed ID: 8002990 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of p34cdc2 kinase activation, p34cdc2 tyrosine dephosphorylation, and mitotic progression in Chinese hamster ovary cells exposed to etoposide. Lock RB Cancer Res; 1992 Apr; 52(7):1817-22. PubMed ID: 1551112 [TBL] [Abstract][Full Text] [Related]
11. Highly synchronous culture of fibroblasts from G2 block caused by staurosporine, a potent inhibitor of protein kinases. Abe K; Yoshida M; Usui T; Horinouchi S; Beppu T Exp Cell Res; 1991 Jan; 192(1):122-7. PubMed ID: 1984408 [TBL] [Abstract][Full Text] [Related]
12. The protein kinase C inhibitor ilmofosine (BM 41 440) arrests cells in G2 phase and suppresses CDC2 kinase activation through a mechanism different from that of DNA damaging agents. Hofmann J; O'Connor PM; Jackman J; Schubert C; Ueberall F; Kohn KW; Grunicke H Biochem Biophys Res Commun; 1994 Mar; 199(2):937-43. PubMed ID: 8135843 [TBL] [Abstract][Full Text] [Related]
13. Growth condition-induced precocious activation of p34cdc2 kinase inhibits the expression of developmental competence. Jantzen H; Schulze I Dev Biol; 1994 Nov; 166(1):311-22. PubMed ID: 7958455 [TBL] [Abstract][Full Text] [Related]
14. The G2/M DNA damage checkpoint inhibits mitosis through Tyr15 phosphorylation of p34cdc2 in Aspergillus nidulans. Ye XS; Fincher RR; Tang A; Osmani SA EMBO J; 1997 Jan; 16(1):182-92. PubMed ID: 9009279 [TBL] [Abstract][Full Text] [Related]
15. Multiple kinase arrest points in the G1 phase of nontransformed mammalian cells are absent in transformed cells. Gadbois DM; Crissman HA; Tobey RA; Bradbury EM Proc Natl Acad Sci U S A; 1992 Sep; 89(18):8626-30. PubMed ID: 1528872 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of p34cdc2 kinase activity by etoposide or irradiation as a mechanism of G2 arrest in Chinese hamster ovary cells. Lock RB; Ross WE Cancer Res; 1990 Jun; 50(12):3761-6. PubMed ID: 2187601 [TBL] [Abstract][Full Text] [Related]
17. Cyclin A-mediated inhibition of intra-Golgi transport requires p34cdc2. Mackay D; Kieckbusch R; Adamczewski J; Warren G FEBS Lett; 1993 Dec; 336(3):549-54. PubMed ID: 8282125 [TBL] [Abstract][Full Text] [Related]
18. Differential regulation of the synthesis and activity of the major cyclin-dependent kinases, p34cdc2, p33cdk2, and p34cdk4, during cell cycle entry and progression in normal human T lymphocytes. Lucas JJ; Szepesi A; Domenico J; Tordai A; Terada N; Gelfand EW J Cell Physiol; 1995 Nov; 165(2):406-16. PubMed ID: 7593219 [TBL] [Abstract][Full Text] [Related]
19. Characterization of synthetic peptide substrates for p34cdc2 protein kinase. Marshak DR; Vandenberg MT; Bae YS; Yu IJ J Cell Biochem; 1991 Apr; 45(4):391-400. PubMed ID: 2045431 [TBL] [Abstract][Full Text] [Related]
20. UCN-01: a potent abrogator of G2 checkpoint function in cancer cells with disrupted p53. Wang Q; Fan S; Eastman A; Worland PJ; Sausville EA; O'Connor PM J Natl Cancer Inst; 1996 Jul; 88(14):956-65. PubMed ID: 8667426 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]